ARTICLE | Financial News
Summit slips on BMN 195 discontinuation
August 3, 2010 11:39 PM UTC
Summit Corp. plc (LSE:SUMM) fell 1.62p (35%) to 3p on Tuesday after partner BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) discontinued development of BMN 195 (formerly SMT C1100) late Monday based on pha...